Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma
Open Access
- 19 September 2008
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 48 (1) , 10-21
Abstract
Tumor suppressor genes (TSGs) are sometimes inactivated by transcriptional silencing through promoter hypermethylation. To identify novel methylated TSGs in melanoma, we carried out global mRNA expression profiling on a panel of 12 melanoma cell lines treated with a combination of 5‐Aza‐2‐deoxycytidine (5AzadC) and an inhibitor of histone deacetylase, Trichostatin A. Reactivation of gene expression after drug treatment was assessed using Illumina whole‐genome microarrays. After qRT‐PCR confirmation, we followed up 8 genes (AKAP12, ARHGEF16, ARHGAP27, ENC1, PPP1R3C, PPP1R14C, RARRES1, and TP53INP1) by quantitative DNA methylation analysis using mass spectrometry of base‐specific cleaved amplification products in panels of melanoma cell lines and fresh tumors. PPP1R3C, ENC1, RARRES1, and TP53INP1, showed reduced mRNA expression in 35–59% of the melanoma cell lines compared to melanocytes and which was correlated with a high proportion of promoter methylation (>40–60%). The same genes also showed extensive promoter methylation in 6–25% of the tumor samples, thus confirming them as novel candidate TSGs in melanoma.Keywords
This publication has 52 references indexed in Scilit:
- Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvementsNucleic Acids Research, 2007
- Epigenetic Silencing of the PTEN Gene in MelanomaCancer Research, 2006
- Cutaneous Malignant MelanomaMayo Clinic Proceedings, 2006
- Trends for in situ and Invasive Melanoma in Queensland, Australia, 1982–2002Cancer Causes & Control, 2006
- Decreased expression of Apaf‐1 with progression of melanomaPigment Cell Research, 2005
- Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridizationOncogene, 2004
- Microarray expression profiling in melanoma reveals a BRAF mutation signatureOncogene, 2004
- Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma developmentInternational Journal of Cancer, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]Human Molecular Genetics, 1998